Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01424982
Title Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

acute lymphoblastic leukemia

Therapies

Cytarabine + Methotrexate + Ponatinib

Rituximab

Ponatinib + Vincristine Sulfate

Cyclophosphamide + Dexamethasone + Doxorubicin + Vincristine Sulfate

Leucovorin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.